Favipiravir Shows Promise Against Chandipura Virus
Recent studies have brought into light the potential of Favipiravir as a treatment for the Chandipura virus (CHPV). Conducted by the National Institute of Virology in Pune, these preclinical trials indicate that Favipiravir can reduce viral load and improve survival rates in infected animals. The Chandipura virus is endemic to central India and primarily affects children, leading to severe symptoms such as high fever and seizures. About the Chandipura Virus The Chandipura virus belongs to the Rhabdoviridae family and is transmitted by sandflies. It was first identified in 1965 in Nagpur, Maharashtra. The virus causes encephalitis, leading to inflammation of the brain. Symptoms include fever, vomiting, altered consciousness, and convulsions. Transmission and Vector CHPV is primarily transmitted by female Phlebotomine sandflies, which are most active during the early monsoon season. Studies have indicated that certain mosquito species, particularly Aedes aegypti, could also trans...